首页> 外文期刊>Indian Journal of Nuclear Medicine >Role of Tc99m sulfur colloid scintigraphy in differentiating non-cirrhotic portal fibrosis from cirrhosis liver
【24h】

Role of Tc99m sulfur colloid scintigraphy in differentiating non-cirrhotic portal fibrosis from cirrhosis liver

机译:Tc99m硫胶体闪烁显像在鉴别非肝硬化门脉纤维化与肝硬化肝中的作用

获取原文
           

摘要

Background:Two most important causes of portal hypertension are cirrhosis of liver and non-cirrhotic portal fibrosis (NCPF). The purpose of this study was to assess the scintigraphic appearances of Tc99m sulfur colloid liver scan in differentiating liver cirrhosis from NCPF.Materials and Methods:Retrospective analysis records of 146 patients (91 male and 55 female) with diffuse hepatocellular disease was done for liver size, liver uptake, spleen size, spleen uptake, colloid shift to bone marrow and lungs.Methods:Retrospective analysis records of 146 patients (91 male and 55 female) with diffuse hepatocellular disease was done for liver size, liver uptake, spleen size, spleen uptake, colloid shift to bone marrow and lungs.Results:Cirrhotic livers showed patchy and lower uptake than NCPF (59% vs. 20%, P-value 0.041). Spleen size was significantly increased in NCPF compared to cirrhosis (100% vs. 67%, P-value 0.0137). Significant colloid shift to bone marrow was noted in cirrhosis (84% vs. 7%, P-value<0.0001).Conclusion:Tc99m sulfur colloid liver scan is a non-invasive procedure having a useful adjunctive role in clinical differentiation of cirrhosis from NCPF.
机译:背景:门脉高压的两个最重要原因是肝硬化和非肝硬化门脉纤维化(NCPF)。这项研究的目的是评估Tc99m硫胶体肝扫描在区分肝硬化和NCPF时的闪烁体征表现。材料与方法:对146例弥漫性肝细胞病患者(91例男性和55例女性)的肝脏大小进行回顾性分析记录。方法:回顾性分析146例弥漫性肝细胞疾病患者(91例男性和55例女性)的肝脏大小,肝脏摄取,脾脏大小,脾脏的回顾性分析记录。肝吸收,脾脏大小,脾脏吸收,脾脏大小,脾脏大小,脾脏大小,脾脏大小,脾脏大小结果:肝硬化肝显示出斑片状且摄取低于NCPF(59%比20%,P值0.041)。与肝硬化相比,NCPF的脾脏大小显着增加(100%比67%,P值0.0137)。肝硬化患者中胶体向骨髓有明显转移(84%vs. 7%,P值<0.0001)。 。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号